Neuroendocrine tumours of the pancreas
Open Access
- 1 February 2000
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 87 (2) , 129-131
- https://doi.org/10.1046/j.1365-2168.2000.01277.x
Abstract
No abstract availableKeywords
Funding Information
- Swedish Cancer Foundation
- Söderberg's Foundation
- Lions Cancer Foundation
This publication has 10 references indexed in Scilit:
- Efficacy and Safety of Prolonged-Release Lanreotide in Patients With Gastrointestinal Neuroendocrine Tumors and Hormone-Related SymptomsJournal of Clinical Oncology, 1999
- Positron emission tomography with 5-hydroxytryprophan in neuroendocrine tumors.Journal of Clinical Oncology, 1998
- Chromogranin A: its clinical value as marker of neuroendocrine tumoursEuropean Journal of Clinical Investigation, 1998
- Prognostic criteria in nonfunctioning pancreatic endocrine tumoursVirchows Archiv, 1996
- OctreotideNew England Journal of Medicine, 1996
- Surgery in Zollinger-Ellison Syndrome Alters the Natural History of GastrinomaAnnals of Surgery, 1994
- An Update of the Medical Treatment of Malignant Endocrine Pancreatic TumorsActa Oncologica, 1993
- Hepatic arterial embolization for metastatic hormone-secreting tumors technique, effectiveness, and complicationsCancer, 1990
- Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumorsCancer, 1990
- Somatostatin and Somatostatin Analogue (SMS 201-995) in Treatment of Hormone-Secreting Tumors of the Pituitary and Gastrointestinal Tract and Non-Neoplastic Diseases of the GutAnnals of Internal Medicine, 1989